CMS Grants Progenics New Technology Add-On Payment for Inpatient Use of AZEDRA

Progenics Pharmaceuticals (NASDAQ:PGNX) has announced that the Centers for Medicare & Medicaid Services (CMS) approved a new technology add-on payment...